Process impurities analysis is a fundamental aspect of chemical development, essential for characterizing and quantifying unwanted chemical species that emerge during synthesis and manufacturing. It answers the critical question: "What trace components exist alongside the main product?" Reliable impurity data is crucial for optimizing synthesis routes, improving yield, and ensuring final product quality. BOC Sciences offers comprehensive process impurities analysis services utilizing a diverse array of advanced analytical techniques. We help clients isolate, identify, and synthesize impurities for drug development projects, providing the definitive data needed to drive successful development decisions.
BOC Sciences delivers customized process impurity analysis with rapid turnaround times, helping you optimize synthetic routes and ensure absolute product purity.
We utilize high-resolution LC-MS testingto provide exact mass data and fragmentation patterns, enabling the rapid identification of complex organic impurities and degradation products at trace levels.
Our GC-MS testing capabilities are perfectly suited for volatile and semi-volatile compounds, providing unparalleled resolution and mass spectral confirmation for residual solvents and volatile by-products.
We deploy multidimensional NMR testing (1D, 2D) for the definitive structural elucidation of isolated impurities, providing detailed insights into molecular connectivity and stereochemistry.
Our robust HPLC testing platform, equipped with various detectors (UV, PDA, CAD, ELSD), is the workhorse for quantitative impurity profiling and purity determination in complex mixtures.
We utilize advanced ICP Testing (ICP-OES, ICP-MS) for the ultra-sensitive detection of elemental impurities, ensuring precise quantification of inorganic catalysts and heavy metal traces.
We integrate diverse spectroscopic and chromatographic tools within our centralized analytical platform to provide orthogonal verification of impurity structures and quantities, ensuring highest confidence in results.
BOC Sciences adapts analytical strategies to suit the unique chemical properties of various product classes, ensuring relevant and accurate impurity assessment.
Submit your compound details and synthetic background. We will design a bespoke analytical strategy to fully characterize your process impurities.
Our analytical experts review your synthetic route to predict potential impurities, select appropriate detection technologies, and define the overall analytical strategy tailored to your molecule.
We perform rigorous method development to ensure baseline resolution of closely eluting peaks and adequate sensitivity to detect trace-level contaminants.
We execute the testing protocols utilizing high-resolution platforms. When necessary, we employ preparative chromatography techniques to isolate unknown peaks for downstream characterization.
Data is thoroughly analyzed using advanced spectroscopic interpretation. A comprehensive final report detailing the structures, origins, and quantitative profiles of the impurities is delivered.
We assist chemists during process R&D by swiftly identifying reaction by-products, helping to pinpoint inefficiencies, map mechanistic pathways, and optimize synthetic conditions. This support also helps development teams better understand impurity trends across experiments and improve route robustness during early process refinement.
For complex custom synthesis campaigns, we provide rigorous impurity profiling to ensure that specialized intermediates and highly customized final compounds meet your strictest purity specifications. Our analytical insight helps clarify impurity sources, support purification decisions, and improve confidence in challenging project execution.
We support internal labs by handling overflow analytical testing and release tasks, acting as a specialized extension of your team to solve particularly challenging impurity isolation problems. This allows clients to maintain routine workflow efficiency while still addressing complex analytical questions with greater depth and speed.
We analyze excipient compatibility and monitor formulation-induced degradation, assisting product development teams in selecting the most stable matrices for their active ingredients. Our work also helps reveal formulation-related impurity risks early, supporting more reliable stability performance and better-informed formulation optimization decisions.
Partner with BOC Sciences to access an elite analytical infrastructure and highly experienced structural chemists. Our agile problem-solving provides the clear, actionable impurity data you need to drive your process development forward.
Our team possesses deep expertise in complex structural elucidation and trace-level quantification, ensuring no unknown peak or degradation product goes unidentified in your matrix.
We offer rigorous method validation to ensure that your analytical procedures are robust, highly reproducible, and perfectly tailored for reliable routine monitoring.
By employing multiple intersecting analytical techniques concurrently, we provide highly confident, cross-verified results for complex and overlapping impurity profiles.
Our consultative approach means we adapt our analytical strategies rapidly in response to unexpected synthesis outcomes or the emergence of new degradation pathways.
Client Needs: A client observed an unknown late-eluting peak during stability testing of a novel small molecule. They needed rapid identification to understand the degradation mechanism and prevent future product loss.
Challenges: The impurity was present at less than 0.1%, making direct structural characterization difficult. Furthermore, the compound was highly unstable when subjected to standard isolation techniques, rapidly converting into secondary degradants.
Solution: BOC Sciences employed preparative liquid chromatography under specialized, cold conditions to accumulate sufficient quantities of the intact degradant. We then utilized high-resolution LC-MS and 2D NMR to achieve complete, definitive structural elucidation.
Outcome: The impurity was unequivocally identified as an oxidative degradant. This actionable data allowed the client to implement a targeted antioxidant strategy in their formulation, completely resolving the stability issue.
Client Needs: A developer required a highly sensitive analytical method to quantify a known alkylating agent (a potential reactive impurity) generated during an early synthetic step to ensure the safety profile of the final material.
Challenges: The required limit of quantitation was in the low parts-per-billion (ppb) range, and the complex compound matrix caused significant ion suppression in standard mass spectrometry methods, masking the trace signals.
Solution: Our analytical team developed a specialized derivatization method followed by GC-MS analysis utilizing selected ion monitoring (SIM). We deeply optimized the sample extraction protocol to entirely eliminate the problematic matrix interference.
Outcome: The method successfully and reproducibly achieved the required ppb sensitivity. Routine testing confirmed that the client's downstream purification process effectively cleared the reactive intermediate, securing the safety of the final compound.
Client Needs: Following a transition to a new catalytic cross-coupling reaction, a client needed to track and rigorously quantify palladium and ruthenium residues across multiple purification cycles to select the best workup strategy.
Challenges: Standard colorimetric spot tests were insufficiently sensitive, and the client needed precise quantitative data to evaluate the efficiency of various commercially available metal scavengers under different conditions.
Solution: BOC Sciences deployed an optimized ICP-MS methodology. We rapidly analyzed samples drawn before and after different scavenger treatments, providing a detailed, highly accurate map of metal clearance throughout the downstream processing steps.
Outcome: The high-precision trace data enabled the client to select the most cost-effective metal scavenger and optimize the contact time, consistently achieving metal levels well below the required safety thresholds across all subsequent batches.
Process impurities analysis is essential in drug development because it directly impacts the controllability and robustness of synthetic routes. By systematically identifying and characterizing impurity sources, development teams can optimize reaction conditions, select better reagents, and reduce uncertainties during scale-up. A deep understanding of impurity profiles also improves process reproducibility, enabling more informed and efficient development decisions.
Impurities in complex processes often arise from side reactions, intermediate degradation, or raw material contributions, requiring integrated analytical approaches such as LC-MS, GC-MS, and NMR. By combining structural elucidation with pathway tracing, key impurity sources can be systematically identified. Service providers like BOC Sciences offer tailored impurity characterization strategies, helping clients rapidly pinpoint root causes and implement effective optimization solutions.
In early development stages, controlling process impurities relies on designing robust synthetic routes and carefully screening reaction conditions. Small-scale evaluations allow early identification of high-risk steps, enabling targeted optimization. Incorporating in-process monitoring or staged analytical checkpoints helps track impurity trends dynamically, reducing later-stage adjustments and improving overall development efficiency.
During process optimization, impurity analysis serves not only as an evaluation tool but also as a decision-making driver. By comparing impurity profiles under different conditions, scientists can identify key parameters affecting reaction selectivity. BOC Sciences leverages extensive process development expertise to correlate impurity data with reaction mechanisms, offering targeted optimization strategies that enhance development outcomes.
When selecting an impurity analysis service provider, key considerations include the breadth of analytical capabilities, project experience, and problem-solving expertise. A strong partner should go beyond routine testing to deliver in-depth structural elucidation and mechanistic insights for complex cases. Additionally, communication efficiency and customization capabilities are critical, as they directly influence project progress and the overall quality of results.
The process impurity analysis conducted by BOC Sciences was executed flawlessly. The trace-level data was precise, and the comprehensive structural elucidation reports gave us the insights needed to optimize our synthesis route confidently.
— Dr. Sullivan, Director of Chemistry, Emerging Biotech
We struggled with co-eluting peaks in our residual solvent analysis. The team at BOC Sciences provided excellent custom method development, achieving baseline resolution that our internal lab couldn't manage. Their scientific input added immense value.
— Dr. Bennett, Analytical Lead, Pharmaceutical Company
Identifying unknowns is often a bottleneck, but BOC Sciences delivered structural confirmation ahead of schedule. Their regular updates and agile problem-solving allowed us to keep our process R&D timeline on track without sacrificing quality.
— Dr. Whitaker, Project Leader, Drug Discovery Institute
Beyond just basic HPLC screening, the integration of high-resolution MS and NMR provided by BOC Sciences helped us confidently map our entire impurity profile. The orthogonal data was seamless and professionally presented.
— Dr. Harrison, VP of CMC, Biopharma Startup
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
